Author:
Tarner Ingo H,Müller-Ladner Ulf,Gay Steffen
Publisher
Springer Science and Business Media LLC
Reference65 articles.
1. Furst DE et al. (2006) Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006. Ann Rheum Dis 65 (Suppl 3): iii2–iii15
2. Pollard L and Choy E (2005) Rheumatoid arthritis: non-tumor necrosis factor targets. Curr Opin Rheumatol 17: 242–246
3. Study to assess the effect of tocilizumab plus methotrexate on signs and symptoms in patients with moderate to severe active rheumatoid arthritis [
http://www.clinicaltrials.gov/ct/show/NCT00106548?order=1
] (accessed 28 March 2007)
4. Choy EH et al. (2002) Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum 46: 3143–3150
5. McInnes IB et al. (2003) New strategies to control inflammatory synovitis: interleukin 15 and beyond. Ann Rheum Dis 62 (Suppl 2): ii51–ii54
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献